絞り込み

16535

広告

Relationship between Paronychia and Drug Concentrations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

著者 Masago K , Irie K , Fujita S , Imamichi F , Okada Y , Katakami N , Fukushima S , Yatabe Y
Oncology.2018 Jun 14 ; ():1-6.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (28view , 0users)

Full Text Sources

Miscellaneous

Molecular Biology Databases

MalaCards for paronychia

The purpose of the study was to evaluate the site of paronychia in patients with non-small cell lung cancer harboring an epidermal growth factor receptor (EGFR) gene activating mutation who were treated with EGFR tyrosine kinase inhibitors (EGFR TKIs).
PMID: 29902802 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード